2025-2026 Regular Session • Kansas Legislature
SB212
Legislative Summary
Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/5/2025
Senate Introduced
Senate
2/6/2025
Senate Referred to Committee on Financial Institutions and Insurance
Senate
Status Information
Current Status
Introduced(2/5/2025)
Chamber
Senate
Committee
Financial Institutions and Insurance(Senate)
Sponsors
Democrat: 1
Primary Sponsor
Dinah Sykes
Democrat